Hashem Koohy, Rafael Perera, Benjamin Schuster-B\u00f6ckler and Clare Verrill will join the Turing network for 2021-2022 to further their research in cancer big data.
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri\u2122 in suspected cancer patients.
Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.
Congratulations to Alistair Easton, Siim Pauklin, Susie Shapiro and their collaborators who have been awarded funding in the second round of the OxCODE Funding Scheme.
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
OxCODE is working under the umbrella of a new pan-divisional initiative at the University of Oxford that brings together the collective force of cancer research, outreach and care that happen across the city of Oxford.
Researchers at the Botnar Research Centre have developed technology that facilitates standalone long-read Oxford Nanopore sequencing of single cells, opening avenues for understanding the causes of diseases like cancer.
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett\u2019s oesophagus and so determine patients most at risk of developing cancer.
A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.
Nina Wietek from the Ahmed lab is investigating fallopian tube tissue to see what we can understand about precancerous mutations in the tissue from which ovarian cancers develops.
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
Dr Chunxiao Song\u2019s team build on its TAPS method to develop an alternative to costly whole-genome sequencing for the detection of DNA methylation.
Professor Eric O\u2019Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
![\"Hashem](\"https://www.oxcode.ox.ac.uk/news/turing-fellowships-for-four-oxcode-members/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n